摘要
目的:观察尿毒清颗粒治疗早期糖尿病肾病的临床疗效。方法:我院早期糖尿病肾病患者68例,随机分为对照组和治疗组各34例。两组均予ACEI(或ARB)降低尿蛋白,治疗组在ACEI(或ARB)基础上加用尿毒清颗粒。两组患者均治疗3个月。观察两组治疗前后糖化血红蛋白(Hemoglobin A1c,HbA1c)、血尿素氮(Blood urea nitrogen,BUN)、血肌酐(Serum creatinine,Scr)、尿白蛋白排泄率(Urine albumin excretion ratio,UAER)水平,并记录不良反应。结果:两组治疗后尿白蛋白排泄率较治疗前均显著下降,治疗组较对照组下降更明显,差别具有统计学意义(P<0.05)。两组治疗后HbA1c、BUN、Scr较治疗前下降,但差别无统计学意义。所有病例均无严重不良反应发生。结论:早期糖尿病肾病患者在常规西药治疗基础上,加用尿毒清颗粒治疗,可以延缓肾功能恶化,而且安全性好。
Objective： To observe the clinical etiicacy oi uremic clearance granule（UCG）in the me treatmem oI early alabetic nephropathy（DN）. Methods： 68 patients with early DN of our hospital were randomized into two groups and each group included 34 cases. Both of the groups were given angiotensin II receptor antagonists or angiotensin converting enzyme inhibitor to control urine protein. The treatment group were additionally given UCG on the basis of control group. After a follow-up of three months, the changes of hemoglobin Alc（ HbAlc）, blood ureanitrogen（BUN）, serum creati- nine（Scr） and urine albumin excretion ratio（UAER）were compared between two groups before and after treatment;Ad- verse drug reaction（ADR）were also recorded. Results：Urinary albumin of two groups decreased significantly after treatment, and the treatment group decreased more significantly than the control group（P〈0. 05）. HbAlc, BUN and Scr of two groups also decreased after treatment. However, there was no statistical significance between two groups. No severe ADR was found in two groups. Conclusion： UCG are effective in the treatment of early DN combine with conventional therapy of western medicine, and can delay deterioration of renal function with sound safety.
出处
《医学理论与实践》
2016年第11期1406-1407,1417,共3页
The Journal of Medical Theory and Practice
关键词
尿毒清颗粒
早期糖尿病肾病
尿白蛋白排泄率
21remic clearance granule, Early diabetic nephropathy, Urine albumin excretion ratio
